Alzheimer's research sees major diagnostic advances in France
Maxime Molina, President of the Board of Directors of the Foundation for Medical Research, reports major advancements in Alzheimer's disease research, particularly regarding diagnosis and prevention. With over 900,000 people affected by the disease in France, researchers have achieved a breakthrough in early detection using non-invasive blood tests. This allows for earlier patient management through non-medicinal solutions and easier integration into clinical trials.
While a cure does not yet exist, research has improved the understanding of the disease's causes, including genetic factors which account for 60% to 80% of cases, as well as environmental and infectious factors. Currently, specific Alzheimer's medications are not available on the French market because their benefit-to-risk ratio is deemed insufficient, despite showing efficacy in a very small number of specific patients.
Entities
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 3 SOURCES] Maxime Molina is the president of the board of directors of the Foundation for Medical Research. www.bienpublic.com · www.republicain-lorrain.fr · www.ledauphine.com
- [● 3 SOURCES] The disease can now be detected earlier and less invasively through a simple blood test. www.bienpublic.com · www.republicain-lorrain.fr · www.ledauphine.com
- [● 3 SOURCES] Genetic explanations are responsible for 60% to 80% of cases in patients. www.bienpublic.com · www.republicain-lorrain.fr · www.ledauphine.com
- [● 3 SOURCES] Alzheimer's disease affects more than 900,000 people in France. www.bienpublic.com · www.republicain-lorrain.fr · www.ledauphine.com
- [● 3 SOURCES] Specific Alzheimer's drugs are not currently on the French market because their benefit-risk ratio is not considered sufficient. www.bienpublic.com · www.republicain-lorrain.fr · www.ledauphine.com
- [● 3 SOURCES] There is currently no cure for Alzheimer's disease. www.bienpublic.com · www.republicain-lorrain.fr · www.ledauphine.com